Locametz Unione Europea - italiano - EMA (European Medicines Agency)

locametz

novartis europharm limited  - gozetotide - imaging dei radionuclidi - radiofarmaci diagnostici - questo medicinale è solo per uso diagnostico. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

METHOTREXATE Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

methotrexate

pfizer italia s.r.l. - metotrexato - metotrexato

TIOGUANINA ASPEN Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

tioguanina aspen

aspen pharma trading limited - tioguanina - tioguanina

CITARABINA HIKMA Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

citarabina hikma

hikma farmaceutica (portugal) s.a. - citarabina - citarabina